Kukje Pharma Company is Drug Discovery in South Korea that focus on Pharma Co Ltd engages business. Founded in 1959. They cover business area such as Kukje Pharma Co Ltd engage, manufacturing, selling, pharmaceutical product, ETC, OTC, raw material, intermediate, side chain product, cosmetic, health care product, its product, cephalosporin, penicillin, quinolone, aminoglycoside, agent.
1959
( 65 years old in 2024 )
Pharma Co Ltd Engages
-
Sangwoo Building
513-2, Yatap-Dong, Bundang-Gu
Seongnam-si, Gyeonggi 463-839
South Korea
Private
Kukje Pharma Co Ltd engagemanufacturingsellingpharmaceutical productETCOTCraw materialintermediateside chain productcosmetichealth care productits productcephalosporinpenicillinquinoloneaminoglycosideagent
* We use standard office opening hours in near Kukje Pharma Company's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Kukje Pharma Company is Drug Discovery business from South Korea that founded in 1959 (65 years old in 2024), Kukje Pharma Company business is focusing on Pharma Co Ltd Engages.
Kukje Pharma Company headquarter office and corporate office address is located in Sangwoo Building 513-2, Yatap-Dong, Bundang-Gu Seongnam-si, Gyeonggi 463-839 South Korea.
Kukje Pharma Company was founded in South Korea.
In 2024, Kukje Pharma Company is currently focus on Pharma Co Ltd engages sector.
Above is snippet of Google Trends for "Pharma Co Ltd engages" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Kukje Pharma Company, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
